Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of the Recurrences of Chronic Bacterial Cystitis

NCT06284265 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT06284265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06284265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of the Recurrences of Chronic Bacterial Cystitis
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 16, 2023
Completion date
December 31, 2026
Enrollment
415 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

cystitis bacterial, cystitis chronic, recurrence of chronic bacterial cystitis